Neuberger Berman Group’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,217
Closed -$29.3K 2184
2025
Q4
$29.3K Buy
+10,217
New +$28.3K ﹤0.01% 2078
2022
Q4
Sell
-2,347,829
Closed -$36.5M 1810
2022
Q3
$36.5M Buy
2,347,829
+235,359
+11% +$5.18M 0.04% 482
2022
Q2
$48.4M Buy
2,112,470
+116,258
+6% +$2.49M 0.05% 427
2022
Q1
$49.2M Buy
1,996,212
+341,315
+21% +$7.71M 0.04% 474
2021
Q4
$45.2M Buy
1,654,897
+1,457,084
+737% +$51M 0.04% 507
2021
Q3
$8.47M Buy
+197,813
New +$8.78M 0.01% 844

Other funds holding DH

Neuberger Berman Group's DH Position: Q1 2026 in Review

Neuberger Berman Group sold out of Definitive Healthcare (DH) in Q1 2026, closing a stake of 10,217 shares — an estimated $29.3K sold.

Neuberger Berman Group first reported a position in DH in Q3 2021 and held it in 6 quarters. The position peaked at $49.2M in Q1 2022. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • Neuberger Berman Group reported no remaining Definitive Healthcare position as of Q1 2026 after selling out during the quarter.
  • Neuberger Berman Group sold 10,217 Definitive Healthcare shares in Q1 2026, an estimated $29.3K.
  • Neuberger Berman Group first reported a position in Definitive Healthcare in Q3 2021 and held it in 6 quarters.
  • Neuberger Berman Group's Definitive Healthcare position peaked at $49.2M in Q1 2022.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.